Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes.
- DOI
- 10.3389/fgene.2022.975987
- Published
- 2022
- Container
- Frontiers in genetics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fgene.2022.975987,
title = {Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes.},
author = {Mossfield T and Soster E and Menezes M and Agenbag G and Dubois ML and Gekas J and Hardy T and Jurkowska M and Kleinfinger P and Loggenberg K and Marchili P and Sirica R and Global Expanded NIPT Consortium},
year = {2022},
journal = {Frontiers in genetics},
doi = {10.3389/fgene.2022.975987},
url = {https://doi.org/10.3389/fgene.2022.975987}
}RIS
TY - JOUR TI - Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes. AU - Mossfield T AU - Soster E AU - Menezes M AU - Agenbag G AU - Dubois ML AU - Gekas J AU - Hardy T AU - Jurkowska M AU - Kleinfinger P AU - Loggenberg K AU - Marchili P AU - Sirica R AU - Global Expanded NIPT Consortium PY - 2022 JO - Frontiers in genetics DO - 10.3389/fgene.2022.975987 UR - https://doi.org/10.3389/fgene.2022.975987 ER -
APA
T, M., E, S., M, M., G, A., ML, D., J, G., T, H., M, J., P, K., K, L., P, M., R, S., & Consortium, G. E. N. (2022). Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes.. Frontiers in genetics. https://doi.org/10.3389/fgene.2022.975987
Source records
- pubmed · retrieved 2026-09-26T11:31:40.102Z